Evidence map›Paper›PMID 31391927›Full record

ReviewClinical liver disease2019

Adenosinergic Signaling in Liver Fibrosis.

Shilpa Tiwari-Heckler, Z Gordon Jiang

Abstract readReview
In one paragraph

Review in Clinical liver disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shilpa Tiwari-HecklerDivision of Gastroenterology and Hepatology Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA.
Z Gordon JiangDivision of Gastroenterology and Hepatology Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA.

Funding

Adenosine deaminase 2 regulates macrophage phenotype and liver fibrosis in nonalcoholic fatty liver diseaseK08DK115883 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI JIANG, ZHENGHUI GORDON · 2018 to 2022
$839k
NIDDK NIH HHS K08 DK115883NIDDK NIH HHS L30 DK118655
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31391927
PMCPMC6677012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.